LBA
ELV icon

Letko, Brosseau & Associates’s Elevance Health ELV Stock Holding History

Letko, Brosseau & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-432,935
Closed -$71.6M – 100
2017
Q1 		$71.6M Sell
432,935
-9,465
-2% -$1.51M 0.67% 47
2016
Q4 		$63.6M Sell
442,400
-21,570
-5% -$2.89M 0.58% 51
2016
Q3 		$58.1M Buy
+463,970
New +$59.9M 0.54% 53

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Letko, Brosseau & Associates's ELV Position: Q2 2017 in Review

Letko, Brosseau & Associates sold out of Elevance Health (ELV) in Q2 2017, closing a stake of 432,935 shares — an estimated $71.6M sold.

Letko, Brosseau & Associates first reported a position in ELV in Q3 2016 and held it in 3 quarters. The position peaked at $71.6M in Q1 2017. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Letko, Brosseau & Associates reported no remaining Elevance Health position as of Q2 2017 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 432,935 Elevance Health shares in Q2 2017, an estimated $71.6M.
  • Letko, Brosseau & Associates first reported a position in Elevance Health in Q3 2016 and held it in 3 quarters.
  • Letko, Brosseau & Associates's Elevance Health position peaked at $71.6M in Q1 2017.
  • 852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2017, filed 10 Aug 2017.